Kyntra Bio, Inc. (KYNB) vs LeonaBio, Inc. (LONA)
A side-by-side comparison of Kyntra Bio, Inc. and LeonaBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KYNB
Kyntra Bio, Inc.
$6.00HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
LONA
LeonaBio, Inc.
$5.54HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
Total return — KYNB vs LONA
growth of $100 · dividends reinvested · last 6yKYNB -99.5% (-58.0%/yr)LONA -96.7% (-43.5%/yr)LONA compounded faster over this window
Log scale — wide-divergence pair
KYNB LONA
KYNB vs LONA: by the numbers
- •KYNB is the larger company ($24M vs $22M market cap).
- •KYNB is profitable (3967.77% net margin) while LONA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | KYNB | LONA |
|---|---|---|
| P/S ratio | 5.26 | N/A |
| P/B ratio | N/A | 0.65 |
Profitability
| Metric | KYNB | LONA |
|---|---|---|
| Gross margin | 91.37% | 0.00% |
| Operating margin | -712.66% | 0.00% |
| Net margin | 3967.77% | 0.00% |
| ROE | N/A | -421.06% |
| ROIC | -78.16% | -248.21% |
Growth (annualized)
| Metric | KYNB | LONA |
|---|---|---|
| Revenue CAGR (5Y) | -51.49% | N/A |
| Total return CAGR (5Y) | -52.67% | -43.13% |
Frequently asked
- Is KYNB or LONA more profitable?
- KYNB runs the higher net margin — KYNB at 3967.77% versus LONA at 0.00%.
- How have KYNB and LONA total returns compared?
- Over the past 5 years, KYNB delivered -52.67% and LONA delivered -43.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.